Precision Medicine: It’s All About Biomarker Testing
Guidelines recommend biomarker testing, but is it done? Next-generation sequencing (NGS) may help...
Read MoreJan 3, 2022
Guidelines recommend biomarker testing, but is it done? Next-generation sequencing (NGS) may help...
Read MoreJul 23, 2021
ASCO Leukemia Annual Meetingv3 Featuring… ELEVATE-RR: Acalabrutinib demonstrates similar...
Read MoreJul 14, 2021
The phase 3 ELEVATE-RR trial was a head-to-head comparison of acalabrutinib versus ibrutinib in previously treated patients with chronic lymphocytic leukemia. The first results of this study demonstrated that acalabrutinib had...
Read MoreJul 14, 2021
Acalabrutinib with or without obinutuzumab demonstrated superior long-term efficacy over obinutuzumab + chlorambucil in patients with chronic lymphocytic leukaemia (CLL). Results from the 4-year follow-up of the ELEVATE-TN study...
Read MoreJun 23, 2021
Final results from the head-to-head ELEVATE-RR Phase III trial of acalabrutinib demonstrated non-inferior progression-free survival (PFS) and statistically significantly fewer events of atrial fibrillation versus ibrutinib in...
Read MoreJun 9, 2021
Electronic monitoring of Covid-19 symptoms wins high marks from patients In the 1980s the...
Read MoreJun 4, 2021
Herpes zoster (HZ) is prevalent in patients with Chronic Lymphocytic Leukemia (CLL) and affects younger patients who require chemotherapy. The risk of developing HZ increases in recipients of first and second line chemotherapy....
Read MoreJun 4, 2021
Survival is significantly improved by calendar period among patients diagnosed after 2004 and treated in the era of advanced therapies. Females and younger patients had a higher probability of long term survival. The survival of...
Read MoreJun 4, 2021
A 24-month phone and app/web-based diet and physical activity intervention that was successful for weight loss in the general population did not result in greater weight loss or improvement in cardiovascular (CV) risk factors...
Read MoreJun 4, 2021
This study demonstrated for the first time that human peripheral blood mononuclear cells (PBMCs) from chronic lymphocytic leukemia (CLL) patients can be converted into NK cells, CD8+ T cells, NKT cells, and TCRγδ T cells...
Read MoreJun 4, 2021
Palliative care and coping in patients with acute myeloid leukemia receiving intensive induction therapy: A mediation analysis of data from a randomized trial. Integrated palliative and oncology care (IPC) as part of...
Read MoreJun 2, 2021
TUESDAY, June 1, 2021 (HealthDay News) – Oncologists may substantially underestimate how many...
Read MoreMay 18, 2021
The ASCO Annual Meeting enters its second year in a virtual setting June 4-8, 2021, to ensure the safety and health of attendees while delivering groundbreaking science in oncology and timely information on clinical application...
Read More